FDA clears Cordis’s Adroit guiding catheter


Cordis has announced that the FDA has cleared its Adroit 6F guiding catheter for use in various coronary anatomies.

According to a company press release, catheter’s innovative hybrid braid wire technology not only enables the production of a guide catheter with the largest lumen size on the US market, it also facilitates better control and back up support. In addition, the new innovative design incorporating a flexible distal segment and soft longer tip allows atraumatic placement and stability.

Celine Martin, worldwide president, Cordis, said: “The new Adroit guiding catheter, allows physicians to have more options for treating a wide range of challenging cases. It accommodates easier advancement of devices with its 0.072” diameter while providing better support and control at the same time. These features enhance treatment options for physicians, including the treatment of cases with complex lesions and those to be conducted using the radial approach.”